| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 57.747 | 69.553 | 149.242 | 76.864 | 0 | 0 | 0 | 442.950 | 444.638 | 0 |
| Total Income - EUR | 57.747 | 69.553 | 149.242 | 76.864 | 0 | 0 | 0 | 442.950 | 444.638 | 0 |
| Total Expenses - EUR | 16.402 | 14.881 | 27.157 | 18.577 | 8.295 | 0 | 943 | 74.004 | 23.343 | 1.163 |
| Gross Profit/Loss - EUR | 41.344 | 54.672 | 122.085 | 58.287 | -8.295 | 0 | -943 | 368.946 | 421.295 | -1.163 |
| Net Profit/Loss - EUR | 39.612 | 52.586 | 118.627 | 56.358 | -8.295 | 0 | -943 | 364.605 | 416.938 | -1.163 |
| Employees | 1 | 1 | 2 | 4 | 0 | 0 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Paula Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 75.115 | 69.503 | 137.798 | 71.764 | 591 | 580 | 570 | 366.340 | 420.048 | 372.855 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 65.269 | 62.124 | 130.737 | 56.497 | 0 | 0 | 0 | 352.925 | 411.069 | 372.404 |
| Cash | 9.845 | 7.379 | 7.061 | 15.267 | 591 | 580 | 570 | 13.416 | 8.979 | 451 |
| Shareholders Funds | 72.046 | 61.976 | 127.857 | 65.419 | 591 | 580 | -336 | 364.268 | 417.027 | 372.855 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 81 | 81 | 81 | 80 |
| Debts | 3.069 | 7.528 | 9.941 | 6.344 | 0 | 0 | 906 | 2.072 | 3.021 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Paula Med Srl